(Q39435616)

11 September 2017

title

Regulation by survivin of cancer cell death induced by F14512, a polyamine-containing inhibitor of DNA topoisomerase II. (English)

1 reference

11 September 2017

1 reference

6

Pierre Formstecher

0 references

Jérome Kluza

3

object named as

Jérome Kluza

0 references

Philippe Marchetti

object named as

Philippe Marchetti

8

0 references

author name string

Caroline Ballot

1

1 reference

11 September 2017

Manel Jendoubi

2

1 reference

11 September 2017

Aurélie Jonneaux

4

1 reference

11 September 2017

William Laine

5

1 reference

11 September 2017

Christian Bailly

7

1 reference

11 September 2017

publication date

1 April 2012

1 reference

11 September 2017

1 reference

11 September 2017

volume

17

1 reference

11 September 2017

issue

4

1 reference

11 September 2017

page(s)

364-376

1 reference

Antitumor conjugates with polyamine vectors and their molecular mechanisms

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

F14512, a potent antitumor agent targeting topoisomerase II vectored into cancer cells via the polyamine transport system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

A fluorescent biomarker of the polyamine transport system to select patients with AML for F14512 treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Preclinical activity of F14512, designed to target tumors expressing an active polyamine transport system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Interactions between the etoposide derivative F14512 and human type II topoisomerases: implications for the C4 spermine moiety in promoting enzyme-mediated DNA cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

An integrated Drosophila model system reveals unique properties for F14512, a novel polyamine-containing anticancer drug that targets topoisomerase II

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Targeting DNA topoisomerase II in cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Apoptosis induced by topoisomerase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Cellular response to etoposide treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Etoposide (VP-16) elicits apoptosis following prolonged G2-M cell arrest in p53-mutated human non-small cell lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Role of O6-alkylguanine-DNA alkyltransferase in the cytotoxic activity of cloretazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Inhibition of mitochondrial respiration mediates apoptosis induced by the anti-tumoral alkaloid lamellarin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Essential role of mitochondria in apoptosis of cancer cells induced by the marine alkaloid Lamellarin D.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Programmed cell death and extrathymic reduction of Vβ8+CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Apoptosis-inducing factor determines the chemoresistance of non-small-cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

A biomarker that identifies senescent human cells in culture and in aging skin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Survivin, cancer networks and pathway-directed drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Characterization of highly frequent epitope-specific CD45RA+/CCR7+/- T lymphocyte responses against p53-binding domains of the human polyomavirus BK large tumor antigen in HLA-A*0201+ BKV-seropositive donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Adriamycin-induced senescence in breast tumor cells involves functional p53 and telomere dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Caspase inhibition switches doxorubicin-induced apoptosis to senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Daunorubicin-induced variations in gene transcription: commitment to proliferation arrest, senescence and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Therapy-Induced Senescence in Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

A p34(cdc2) survival checkpoint in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Survivin and escaping in therapy-induced cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

Recent advances in anti-survivin treatments for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10495-011-0681-2

10.1007/S10495-011-0681-2

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference